Case Report: A Case of Late-Onset Combined Methylmalonic Acidemia and Hyperhomocysteinemia Induced by a Vegetarian Diet

por Xu, Bei, Zhang, Lihong, Chen, Qiang, Wang, Yajuan, Peng, Yahong, Tang, Hui
Publicado 2022

12. Randomized Studies of Two Clostridioides (Clostridium) difficile Vaccine Formulations

por Lawrence, Jody, Kitchin, Nicholas, Anderson, Annaliesa S, Pride, Michael W, Jansen, Kathrin U, Gruber, William C, Peng, Yahong, Yi, Kevin, Knirsch, Charles, Webber, Chris
Publicado 2020

16. A Randomized Phase 1 Study of a Novel Pneumococcal Conjugate Vaccine in Healthy Japanese Adults in the United States

por Fitz-Patrick, David, Young Jr., Mariano, Scott, Daniel, Scully, Ingrid L, Baugher, Gary, Peng, Yahong, Jansen, Kathrin U, Gruber, William C, Watson, Wendy
Publicado 2020

A randomized phase 1 study of the safety and immunogenicity of 2 novel pneumococcal conjugate vaccines in healthy Japanese adults in the United States

por Fitz-Patrick, David, Young Jr, Mariano, Scott, Daniel A., Scully, Ingrid L., Baugher, Gary, Peng, Yahong, Jansen, Kathrin U., Gruber, William, Watson, Wendy
Publicado 2021

A Phase 2 Study Evaluating the Safety, Tolerability, and Immunogenicity of Two 3-Dose Regimens of a Clostridium difficile Vaccine in Healthy US Adults Aged 65 to 85 Years

por Kitchin, Nicholas, Remich, Shon A, Peterson, James, Peng, Yahong, Gruber, William C, Jansen, Kathrin U, Pride, Michael W, Anderson, Annaliesa S, Knirsch, Charles, Webber, Chris
Publicado 2020

Randomized trial to evaluate the safety, tolerability, and immunogenicity of a booster (third dose) of BNT162b2 COVID-19 vaccine coadministered with 20-valent pneumococcal conjugat...

por Fitz-Patrick, David, Young, Mariano, Yacisin, Kari, McElwee, Kathleen, Belanger, Todd, Belanger, Kelly, Peng, Yahong, Lee, Dung-Yang, Gruber, William C., Scott, Daniel A., Watson, Wendy
Publicado 2023

Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer’s Disease

por Hüll, Michael, Sadowsky, Carl, Arai, Heii, Leterme, Ghislaine Le Prince, Holstein, Ann, Booth, Kevin, Peng, Yahong, Yoshiyama, Tamotsu, Suzuki, Hideo, Ketter, Nzeera, Liu, Enchi, Ryan, J. Michael
Publicado 2017

1240. Persistence of Circulating Antibody Through 12 Months Following Vaccination With a 20-Valent Pneumococcal Conjugate Vaccine in Adults 60–64 Years of Age

por Hurley, Donald, Griffin, Carl, Young Jr., Mariano, Scott, Daniel, Pride, Michael W, Scully, Ingrid L, Ginis, John, Peng, Yahong, Jansen, Kathrin U, Gruber, William C, Watson, Wendy
Publicado 2020

1236. Safety and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Healthy Infants in the United States

por Senders, Shelly, Klein, Nicola P, Lamberth, Erik, Thompson, Allison, Drozd, Jelena, Trammel, James, Peng, Yahong, Giardina, Peter, Jansen, Kathrin U, Gruber, William C, Scott, Daniel, Watson, Wendy
Publicado 2020

Immunogenicity of a 20-valent pneumococcal conjugate vaccine in adults 18 to 64 years old with medical conditions and other factors that increase risk of pneumococcal disease

por Sabharwal, Charu, Sundaraiyer, Vani, Peng, Yahong, Moyer, Lisa, Belanger, Todd J., Gessner, Bradford D., Jodar, Luis, Jansen, Kathrin U., Gruber, William C., Scott, Daniel A., Watson, Wendy
Publicado 2022

3. Phase 3 Pivotal Evaluation of 20-valent Pneumococcal Conjugate Vaccine (PCV20) Safety, Tolerability, and Immunologic Noninferiority in Participants 18 Years and Older

por Essink, Brandon, Sabharwal, Charu, Xu, Xia, Sundaraiyer, Vani, Peng, Yahong, Moyer, Lisa, Pride, Michael W, Scully, Ingrid L, Jansen, Kathrin U, Gruber, William C, Scott, Daniel, Watson, Wendy
Publicado 2020

Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants in the United States

por Senders, Shelly, Klein, Nicola P., Lamberth, Erik, Thompson, Allison, Drozd, Jelena, Trammel, James, Peng, Yahong, Giardina, Peter C., Jansen, Kathrin U., Gruber, William C., Scott, Daniel A., Watson, Wendy
Publicado 2021

1728. Immune Responses to Cross-Reactive Serotypes 6C and 15C After 20-Valent Pneumococcal Conjugate Vaccine in Infants

por Tamimi, Noor, Kline, Mary J, Center, Kimberly J, Thompson, Allison, Baugher, Gary, Drozd, Jelena, Scully, Ingrid L, Giardina, Peter, Trammel, James, Lei, Lanyu, Peng, Yahong, Scott, Daniel, Gruber, William C, Watson, Wendy
Publicado 2023

Safety and immunogenicity of a multivalent pneumococcal conjugate vaccine given with 13-valent pneumococcal conjugate vaccine in healthy infants: A phase 2 randomized trial

por Simon, Michael W., Bataille, Regine, Caldwell, Nicole S., Gessner, Bradford D., Jodar, Luis, Lamberth, Erik, Peng, Yahong, Scott, Daniel A., Lei, Lanyu, Giardina, Peter C., Gruber, William C., Jansen, Kathrin U., Thompson, Allison, Watson, Wendy
Publicado 2023

Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years

por Essink, Brandon, Sabharwal, Charu, Cannon, Kevin, Frenck, Robert, Lal, Himal, Xu, Xia, Sundaraiyer, Vani, Peng, Yahong, Moyer, Lisa, Pride, Michael W, Scully, Ingrid L, Jansen, Kathrin U, Gruber, William C, Scott, Daniel A, Watson, Wendy
Publicado 2021

1944. Tolerability and Safety of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Infants and Older Children in Global Studies

por Flint, Laurence, McElwee, Kathleen, Ouedraogo, G Laissa, Tamimi, Noor, Kline, Mary J, Center, Kimberly J, Thompson, Allison, de Solom, Richard, Yamaji, Masako, Trammel, James, Lei, Lanyu, Peng, Yahong, Gruber, William C, Scott, Daniel, Watson, Wendy
Publicado 2023

Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blind...

por Absalon, Judith, Segall, Nathan, Block, Stan L, Center, Kimberly J, Scully, Ingrid L, Giardina, Peter C, Peterson, James, Watson, Wendy J, Gruber, William C, Jansen, Kathrin U, Peng, Yahong, Munson, Samantha, Pavliakova, Danka, Scott, Daniel A, Anderson, Annaliesa S
Publicado 2021